Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Novanta Inc. (NOVT) Stock Forecast & Price Prediction United States | NASDAQ | Technology | Scientific & Technical Instruments
$138.31
+2.03 (1.49%)Did NOVT Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Novanta is one of their latest high-conviction picks.
Based on our analysis of 3 Wall Street analysts, NOVT has a bullish consensus with a median price target of $157.00 (ranging from $144.00 to $170.00). The overall analyst rating is Strong Buy (9.3/10). Currently trading at $138.31, the median forecast implies a 13.5% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Robert Mason at Baird, suggesting a 4.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for NOVT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 30, 2026 | Baird | Robert Mason | Outperform | Upgrade | $144.00 |
| Aug 11, 2025 | Baird | Robert Mason | Neutral | Maintains | $133.00 |
| Mar 3, 2025 | Baird | Robert Mason | Neutral | Maintains | $160.00 |
| Nov 6, 2024 | Baird | Robert Mason | Neutral | Maintains | $169.00 |
| Aug 7, 2024 | Baird | Robert Mason | Neutral | Maintains | $175.00 |
| May 11, 2023 | Baird | Robert Mason | Neutral | Maintains | $161.00 |
| May 11, 2022 | William Blair | Brian Drab | Outperform | Upgrade | $N/A |
| Nov 13, 2020 | Berenberg | Hold | Initiates | $N/A | |
| May 13, 2020 | Baird | Neutral | Maintains | $90.00 | |
| Feb 28, 2019 | Baird | Neutral | Maintains | $81.00 | |
| May 9, 2018 | Baird | Neutral | Downgrade | $N/A | |
| Feb 27, 2018 | William Blair | Outperform | Initiates | $N/A | |
| Dec 8, 2017 | Baird | Outperform | Initiates | $N/A |
The following stocks are similar to Novanta based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Novanta Inc. has a market capitalization of $4.93B with a P/E ratio of 94.5x. The company generates $980.60M in trailing twelve-month revenue with a 5.5% profit margin.
Revenue growth is +8.5% quarter-over-quarter, while maintaining an operating margin of +11.7% and return on equity of +5.2%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Designs and manufactures precision photonic components.
Novanta generates revenue by designing, manufacturing, and selling precision photonic and motion control components and subsystems to various industries, including healthcare and industrial applications. Their products, such as lasers and beam delivery systems, enhance production quality and are essential in advanced technological processes.
The company is based in Bedford, Massachusetts, and operates globally, allowing it to cater to a diverse range of clients. Novanta's commitment to innovation and quality positions it as a significant player in the industrial and technological sectors.
Technology
Scientific & Technical Instruments
3,000
Mr. Matthijs Glastra
United States
1999
Ouster (OUST) delivered earnings and revenue surprises of +19.36% and +6.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Novanta Inc. (NASDAQ: NOVT) will announce Q1 2026 results on May 11, 2026, after market close, followed by a conference call on May 12 at 8:00 a.m. ET. Dial-in number: (888) 346-3959.
Novanta Inc.'s upcoming earnings release and conference call could influence stock price and investor sentiment, providing insights into the company's financial health and market performance.
Novanta Inc. (NASDAQ: NOVT) joined NVIDIA's Halos AI Systems Inspection Lab to accelerate certification for AI-driven systems, enhancing trust in robotics and physical AI components.
Novanta's partnership with NVIDIA in the Halos AI Systems Inspection Lab enhances its credibility in AI-driven systems, potentially boosting market position and attracting investment in robotics.
Harvey Partners acquired 304,000 shares of Novanta in Q4, resulting in a $36.17 million increase in the value of their position by quarter-end.
Harvey Partners' significant acquisition of Novanta shares indicates strong confidence in the company's future, potentially driving stock prices higher and attracting further investor interest.
CEO Matthijs Glastra sold 7,500 shares for ~$1.09 million on Feb. 10, 2026, representing 6.29% of his total holdings.
CEO Matthijs Glastra's sale of 7,500 shares may signal a lack of confidence in the company's near-term prospects, potentially influencing investor sentiment and stock price.
CEO Matthijs Glastra sold 6,500 shares on February 2, 2026, for about $878,458.68, representing 5.17% of his total holdings.
CEO Matthijs Glastra's sale of 5.17% of his shares may signal potential concerns about the company's future performance, affecting investor confidence and stock price.
Novanta Inc. (NOVT) held its Q4 2025 earnings call, discussing financial performance and future outlook. Specific details from the call will provide insights for investors.
Novanta Inc.'s Q4 2025 earnings call reveals financial performance, growth prospects, and strategic direction, impacting investor sentiment and stock valuation.
Based on our analysis of 3 Wall Street analysts, Novanta Inc. (NOVT) has a median price target of $157.00. The highest price target is $170.00 and the lowest is $144.00.
According to current analyst ratings, NOVT has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $138.31. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict NOVT stock could reach $157.00 in the next 12 months. This represents a 13.5% increase from the current price of $138.31. Please note that this is a projection by Wall Street analysts and not a guarantee.
Novanta generates revenue by designing, manufacturing, and selling precision photonic and motion control components and subsystems to various industries, including healthcare and industrial applications. Their products, such as lasers and beam delivery systems, enhance production quality and are essential in advanced technological processes.
The highest price target for NOVT is $170.00 from at , which represents a 22.9% increase from the current price of $138.31.
The lowest price target for NOVT is $144.00 from Robert Mason at Baird, which represents a 4.1% increase from the current price of $138.31.
The overall analyst consensus for NOVT is bullish. Out of 3 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $157.00.
Stock price projections, including those for Novanta Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.